CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine

Author:

Chanchal Dilip Kumar12,Chaudhary Jitendra Singh1ORCID,Kumar Pushpendra3ORCID,Agnihotri Neha4ORCID,Porwal Prateek2ORCID

Affiliation:

1. Department of Pharmacy, Smt. Vidyawati College of Pharmacy, Jhansi, Uttar Pradesh, India

2. Glocal School of Pharmacy, Glocal University Mirzapur Pole, Saharanpur - 247121, Uttar Pradesh, India

3. Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Saifai, Etawah 206130, Uttar Pradesh, India

4. Department of Pharmacy, Maharana Pratap College of Pharmacy, Kothi, Mandhana, Kanpur-209217, Uttar Pradesh, India

Abstract

Abstract: With the discovery of CRISPR-Cas9, drug development and precision medicine have undergone a major change. This review article looks at the new ways that CRISPR-based therapies are being used and how they are changing the way medicine is done. CRISPR technology's ability to precisely and flexibly edit genes has opened up new ways to find, validate, and develop drug targets. Also, it has made way for personalized gene therapies, precise gene editing, and advanced screening techniques, all of which hold great promise for treating a wide range of diseases. In this article, we look at the latest research and clinical trials that show how CRISPR could be used to treat genetic diseases, cancer, infectious diseases, and other hard-to-treat conditions. However, ethical issues and problems with regulations are also discussed in relation to CRISPR-based therapies, which shows how important it is to use them safely and responsibly. As CRISPR continues to change how drugs are made and used, this review shines a light on the amazing things that have been done and what the future might hold in this rapidly changing field.

Publisher

Bentham Science Publishers Ltd.

Reference177 articles.

1. Labanca N.; Pereira Â.G.; Watson M.; Krieger K.; Padovan D.; Watts L.; Moezzi M.; Wallenborn G.; Wright R.; Laes E.; Fath B.D.; Ruzzenenti F.; De Moor T.; Bauwens T.; Mehta L.; Transforming innovation for decarbonisation? Insights from combining complex systems and social practice perspectives. Energy Res Soc Sci 2020,65,101452

2. Wang X.; Xiong E.; Tian T.; Cheng M.; Lin W.; Wang H.; Zhang G.; Sun J.; Zhou X.; Clustered regularly interspaced short palindromic repeats/Cas9-mediated lateral flow nucleic acid assay. ACS Nano 2020,14(2),2497-2508

3. Harry A.A.; AI’s healing touch: Examining machine learning’s transformative effects on healthcare. BULLET : J Multidisiplin Ilmu 2023,2(4),1134-1145

4. Ansori A.N.; Antonius Y.; Susilo R.J.; Hayaza S.; Kharisma V.D.; Parikesit A.A.; Zainul R.; Jakhmola V.; Saklani T.; Rebezov M.; Ullah M.E.; Application of CRISPR- Cas9 genome editing technology in various fields: A review. Narra J 2023,2(4)

5. Carey N.; Hacking the Code of Life: How gene editing will rewrite our futures Icon Books 2019

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

2. Peptide-Based Drugs: Development and Therapeutic Applications;Journal for Research in Applied Sciences and Biotechnology;2024-08-25

3. Economic Viability of Cutting-Edge Genetic Treatments: Balancing Innovation and Fiscal Sustainability in India's Healthcare Sector;Journal Healthcare Treatment Development;2024-07-16

4. CRISPR/Cas9 gene editing: a novel strategy for fighting drug resistance in respiratory disorders;Cell Communication and Signaling;2024-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3